Invention Grant
- Patent Title: Sustained release vaccine composition
-
Application No.: US11629681Application Date: 2005-06-16
-
Publication No.: US09750797B2Publication Date: 2017-09-05
- Inventor: Malcolm Brandon , Serge Martinod
- Applicant: Malcolm Brandon , Serge Martinod
- Applicant Address: US TX Fort Worth
- Assignee: VIRBAC CORPORATION
- Current Assignee: VIRBAC CORPORATION
- Current Assignee Address: US TX Fort Worth
- Agency: Westerman, Hattori, Daniels & Adrian, LLP
- Priority: AU2004903283 20040616; AU2005900928 20050228
- International Application: PCT/AU2005/000869 WO 20050616
- International Announcement: WO2005/123120 WO 20051229
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K39/02 ; A61K47/24 ; A61K39/39 ; A61K39/08 ; A61K39/112 ; A61K9/00 ; A61K39/108 ; A61K39/00
Abstract:
A non-liquid vaccine composition including one or more antigen component(s); a pharmaceutically acceptable non-liquid adjuvant therefor; and optionally a non-liquid vaccine protection agent.
Public/Granted literature
- US20080199491A1 Sustained Release Vaccine Composition Public/Granted day:2008-08-21
Information query
